Finding 580935 (2023-003)

Material Weakness
Requirement
I
Questioned Costs
-
Year
2023
Accepted
2023-12-15

AI Summary

  • Core Issue: There is a material weakness in internal controls over compliance with federal procurement requirements.
  • Impacted Requirements: Non-compliance with 2 CFR 200.303(a) and 2 CFR 200.320 regarding effective internal controls and documented procurement procedures.
  • Recommended Follow-Up: Management should reevaluate all vendors used before federal funding and update procurement policies to align with Uniform Guidance.

Finding Text

2023-003 Procurement; Federal Agency: Department of Health and Human Services; Program: Social Services Research and Demonstration (ALN 93.647); Pass-through Entity: N/A; Federal Assistance Identification Number or Pass-Through Numbers: N/A; Federal Award Years: Year ended June 30, 2023; Type of Finding: Material Weakness in Internal Control over Compliance; Other Matter Compliance Finding; Criteria: 2 CFR 200.303(a) requires that each non-Federal entity must "Establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award." 2 CFR 200.320 requires that each non-Federal entity must "have and use documented procurement procedures, consistent with the standards of this section and §§ 200.317, 200.318, and 200.319 for any of the following methods of procurement used for the acquisition of property or services required under a Federal award or sub-award." Condition: While testing the procurement requirement, we were able to test compensating controls, but noted that internal controls were not properly designed over the procurement requirement. Prior to receiving federal funding beginning in August 2022, the program conducted a request for proposal (RFP) process and began contracting with a vendor. When federal funding was obtained, the vendor was not reevaluated in accordance with the Uniform Guidance to ensure the procurement requirements were being met. In addition, we noted UW Health – Madison’s procurement policy documents do not include all of the information that is required by the Uniform Guidance. Cause: Because the vendor was already in place for the program prior to receiving federal funds, management did not recognize the need to reevaluate the vendor under the requirements of the Uniform Guidance. In addition, management also did not recognize the need to include additional information in its procurement policy documents related to the Uniform Guidance. Effect: Without appropriate internal controls, there is an increased risk of noncompliance related to federal funding. Context: We identified and tested one vendor that was direct and material to the program and related to the procurement and suspension and debarment requirements. The sample size was based on guidance from chapter 11 of the AICPA Audit Guide, Government Auditing Standards and Single Audits.Questioned Costs: None. Repeat Finding?: No; Recommendation: While it was determined that the requirements of the Uniform Guidance were met related to the vendor tested, we suggest that management reevaluate all vendors that were previously used prior to receiving federal funding. In addition, we recommend that management update its procurement policies to incorporate the requirements of the Uniform Guidance. View of responsible officials of the auditee: Management agrees with the finding. See corrective action plan.

Categories

Procurement, Suspension & Debarment Subrecipient Monitoring

Other Findings in this Audit

  • 4491 2023-001
    Material Weakness
  • 4492 2023-002
    Significant Deficiency
  • 4493 2023-003
    Material Weakness
  • 580933 2023-001
    Material Weakness
  • 580934 2023-002
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.498 Provider Relief Fund $26.99M
93.647 Social Services Research and Demonstration $887,417
93.959 Block Grants for Prevention and Treatment of Substance Abuse $432,204
93.778 Medical Assistance Program $396,480
93.153 Coordinated Services and Access to Research for Women, Infants, Children, and Youth $75,761
93.917 Hiv Care Formula Grants $69,716
93.217 Family Planning_services $60,432
93.110 Maternal and Child Health Federal Consolidated Programs $24,730
93.080 Blood Disorder Program: Prevention, Surveillance, and Research $12,072
93.667 Social Services Block Grant $7,656
93.558 Temporary Assistance for Needy Families $4,069